Actipulse Neuroscience®

📍 Cambridge, United States🗓 Founded 2017👥 31 employees💰 Last funded Sep 2022
Mental Health Care🌐 actipulseneuroscience.com
Website LinkedIn
Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment.
3
Total investors
0
Early stage
3
Mid stage
0
Late stage
2017
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Thailand
1
Investor activity2021–2022 · investors recorded per year
2021220221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Actipulse Neuroscience®?
Actipulse Neuroscience® has 3 investors on record on gritt.io, 3 mid-stage.
When did Actipulse Neuroscience® last raise funding?
The most recent investment in Actipulse Neuroscience® recorded on gritt.io was in September 2022.
When was Actipulse Neuroscience® founded?
Actipulse Neuroscience® was founded in 2017.
What industry is Actipulse Neuroscience® in?
Actipulse Neuroscience® operates in Mental Health Care. Find similar Mental Health Care investors on gritt.io.
Where is Actipulse Neuroscience® based?
Actipulse Neuroscience® is headquartered in Cambridge, United States.